A targeted isotope dilution mass spectrometry assay for Osteopontin quantification in plasma of metastatic breast cancer patients
A. Leslie, E. Teh, A. Drucker, D. M. Pinto
This paper develops a targeted isotope dilution mass spectrometry assay for quantifying osteopontin in plasma of metastatic breast cancer patients, achieving a detection limit of 39 ng/mL.
bioRxiv · Jan 25, 2023Biochemistry